Salanersen is named as a drug or biological intervention in 3 clinical trials in our USA and China trial registers, 3 of which are recruiting. The lead sponsor is Biogen. Registered phase: Phase 3. Conditions studied include Muscular Atrophy, Spinal; Spinal Muscular Atrophy.
| NCT ID | Study | Phase | Status |
|---|---|---|---|
| NCT07221669 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA) (ClinicalTrials.gov ↗) Muscular Atrophy, Spinal |
Phase 3 | Recruiting |
| NCT07444450 | A Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (ClinicalTrials.gov ↗) Muscular Atrophy, Spinal |
Phase 3 | Recruiting |
| NCT07444476 | A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety in Participants Aged 15 to 60 Years With Spinal Muscular Atrophy (SMA) Who Are Either New to SMA Treatment or Were Previously Treated With Risdiplam (ClinicalTrials.gov ↗) Spinal Muscular Atrophy |
Phase 3 | Recruiting |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Muscular Atrophy, Spinal | 2 |
| Spinal Muscular Atrophy | 1 |
| Lead sponsor | Trials |
|---|---|
| Biogen | 3 |
| Register | Salanersen trials |
|---|---|
| Clinical trials in USA | 3 |
| Clinical trials in China | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records — it is not written from memory, and nothing here describes how Salanersen works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Salanersen (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.